Curability of poor-risk metastatic sarcomatoid renal cell carcinoma with the combination of gemcitabine, 5-fluorouracil, and interferon-alfa: a case report of a 55-year-old man with a 10-year complete remission

Clin Genitourin Cancer. 2013 Sep;11(3):370-3. doi: 10.1016/j.clgc.2013.04.005. Epub 2013 May 9.
No abstract available

Keywords: 5-Fluorouracil; Biochemotherapy; Gemcitabine; Interferon-alfa; Metastatic Carcinoma; Sarcomatoid Renal Cell carcinoma.

Publication types

  • Case Reports

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use
  • Carcinoma, Renal Cell / drug therapy*
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Fluorouracil / therapeutic use*
  • Gemcitabine
  • Humans
  • Immunologic Factors / therapeutic use
  • Interferon-alpha / therapeutic use*
  • Kidney Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Remission Induction

Substances

  • Antimetabolites, Antineoplastic
  • Immunologic Factors
  • Interferon-alpha
  • Deoxycytidine
  • Fluorouracil
  • Gemcitabine